H pylori Raises Phosphate Binder Pill Burden in Dialysis H pylori Raises Phosphate Binder Pill Burden in Dialysis
If those with Helicobacter pylori don ' t take a proton pump inhibitor or sodium bicarbonate, they have a higher phosphate binder pill burden, researchers report, between six and nine tablets a day.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news

FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors
Update: 3/23/2011 FDA has determined an osteoporosis and fracture warning on the over-the-counter (OTC) proton pump inhibitor (PPI) medication “Drug Facts” label is not indicated at this time. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 18, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Heartburn Drugs Again Tied to Fatal Risks
Research in recent years has linked long-term use of drugs called proton pump inhibitors (PPIs) to increased risks of various diseases and premature death. These latest findings point to the specific causes of death. (Source: WebMD Health)
Source: WebMD Health - June 6, 2019 Category: Consumer Health News Source Type: news

Large placebo-controlled trial confirms safety of proton pump inhibitors (PPIs)
(American Gastroenterological Association) For patients taking proton pump inhibitors (PPIs) to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest. In a large, multi-year, randomized trial studying the safety of proton pump inhibitors (PPIs), researchers find no evidence to support claims that PPIs cause serious health issues such as pneumonia, chronic kidney disease, diabetes and dementia. This research is published in Gastroenterology, the official journal of the American Gastroenterological Association, as an article in press. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2019 Category: International Medicine & Public Health Source Type: news

Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use
FRIDAY, May 31, 2019 -- Taking proton pump inhibitors (PPIs) is associated with an excess of cause-specific mortality, according to a study published online May 30 in The BMJ. Yan Xie, M.P.H., from St. Louis Health Care System, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2019 Category: Pharmaceuticals Source Type: news

Heartburn drugs linked to fatal heart and kidney disease, stomach cancer
(Washington University in St. Louis) A study by researchers at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System has linked long-term use of such popular heartburn drugs -- called proton pump inhibitors (PPIs) -- to fatal cases of cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer. More than 15 million Americans have prescriptions for PPIs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 30, 2019 Category: Cancer & Oncology Source Type: news

Improper Proton Pump Inhibitor Prescriptions Criticized Improper Proton Pump Inhibitor Prescriptions Criticized
Popularity of the stomach- and intestine-protecting drugs has skyrocketed, but related adverse events, like osteoporotic fractures, C difficile infection, and pneumonia, are problematic.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Antibiotics, PPIs Tied to Higher C. Diff Risk in Hospitalized Children
THURSDAY, March 21, 2019 -- Previous antibiotic exposure and use of proton pump inhibitors (PPIs) may be risk factors for Clostridioides (formerly Clostridium) difficile infection (CDI) in hospitalized pediatric patients, according to a review... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Antibiotics and PPIs linked to increased risk of infectious diarrhea in children
(Society for Healthcare Epidemiology of America) Prior antibiotic exposure and use of acid suppressing medications known as proton pump inhibitors (PPIs) may increase the risk for hospitalized children to contract dangerous Clostridioides difficile infections, according to a study published today in Infection Control& Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 7, 2019 Category: Infectious Diseases Source Type: news

Slow Medicine: Why Are We Lukewarm About PPIs in the ICU?
(MedPage Today) -- Let ' s look at the research (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 4, 2019 Category: Gastroenterology Source Type: news

Proton pump inhibitor therapy may not improve diabetes treatment
Research, published inMetabolic Syndrome and Related Disorders, suggests that proton pump inhibitor therapy does not improve on methods to control blood sugar levels in type-2 diabetes patients.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 4, 2019 Category: Endocrinology Source Type: news

Proton Pump Inhibitors (PPIs) Drug Class
Title: Proton Pump Inhibitors (PPIs) Drug ClassCategory: MedicationsCreated: 6/7/2001 12:00:00 AMLast Editorial Review: 2/27/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - February 27, 2019 Category: Nutrition Source Type: news

Relief of Heartburn in Patients With Erosive Esophagitis Relief of Heartburn in Patients With Erosive Esophagitis
Does a new potassium-competitive acid blocker, vonoprazan, provide more rapid relief of heartburn than standard treatment with a proton-pump inhibitor?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 21, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Another ICU Intervention That May Not Work as Advertised Another ICU Intervention That May Not Work as Advertised
Dr Aaron Holley on the continued debate over whether PPIs truly limit GI bleeding in this setting.Medscape Critical Care (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 24, 2019 Category: Intensive Care Tags: Critical Care Viewpoint Source Type: news

Connecting the Dots Between Heartburn Drugs and Kidney Damage
THURSDAY, Jan. 24, 2019 -- Just because a medication is available over the counter doesn ' t mean it won ' t have side effects or pose other dangers. One example is PPIs, a popular type of heartburn medication that can harm the kidneys, especially when... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 24, 2019 Category: General Medicine Source Type: news